LONA
insider transactionsLeonaBio, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
56.0K sh
Own New
-
Grant·A
Director
$0
56.0K sh
Own New
-
Grant·A
Director
$0
56.0K sh
Own New
-
Grant·A
Robert Renninger KEY
CHIEF FINANCIAL OFFICER
$0
300.0K sh
Own New
-
Grant·A
GENERAL COUNSEL and CCO
$0
300.0K sh
Own New
-
Grant·A
CHIEF MEDICAL OFFICER
$0
350.0K sh
Own New
-
Grant·A
Director
$0
28.0K sh
Own New
-
Grant·A
Director
$0
28.0K sh
Own New
-
Grant·A
PRESIDENT and CEO
$0
750.0K sh
Own New
-
Grant·A
Director
$0
28.0K sh
Own New
-
Grant·A
Director
$0
28.0K sh
Own New
-
Grant·A
Director
$0
28.0K sh
Own New
-
Grant·A
CHIEF SCIENTIFIC OFFICER
$0
300.0K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 5, 2026 | Peter B. Silverman | Grant A | 56.0K | $0 |
| May 5, 2026 | Natalie C. Holles | Grant A | 56.0K | $0 |
| May 5, 2026 | Fred Callori | Grant A | 56.0K | $0 |
| Apr 9, 2026 | Robert Renninger KEY | Grant A | 300.0K | $0 |
| Apr 9, 2026 | Mark Worthington | Grant A | 300.0K | $0 |
| Apr 9, 2026 | Javier San Martin | Grant A | 350.0K | $0 |
| Apr 9, 2026 | Kelly A Romano | Grant A | 28.0K | $0 |
| Apr 9, 2026 | Michael A. Panzara | Grant A | 28.0K | $0 |
| Apr 9, 2026 | Mark James Litton KEY | Grant A | 750.0K | $0 |
| Apr 9, 2026 | Grant Pickering | Grant A | 28.0K | $0 |
| Apr 9, 2026 | James A Johnson | Grant A | 28.0K | $0 |
| Apr 9, 2026 | John M Fluke JR | Grant A | 28.0K | $0 |
| Apr 9, 2026 | Kevin Church | Grant A | 300.0K | $0 |
About LONA insider trading
This page tracks insider transactions for LeonaBio, Inc. (LONA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.